Biopharma Looks to the Netherlands as European Hub
The recent move of the European Medicines Agency from London to Amsterdam is a reflection of the city’s vibrant life sciences and health sector and supporting industries.
Biopharma Looks to the Netherlands as European Hub
Biopharma Looks to the Netherlands as European Hub
The recent move of the European Medicines Agency from London to Amsterdam is a reflection of the city’s vibrant life sciences and health sector and supporting industries.
The recent move of the European Medicines Agency from London to Amsterdam is a reflection of the city’s vibrant life sciences and health sector and supporting industries.
Watch as Nobel laureate Venki Ramakrishnan, who wrote the December Reading Frames essay, discusses Brexit and the importance of sharing scientific insights with the public.
As Britain’s departure date from the European Union approaches, drugmakers are preparing for potential changes to regulatory procedures and border controls.